U.S. flag

An official website of the United States government

Filters

See more specimen types...

Other countries

Results: 1 to 5 of 5

Tests names and labsConditionsGenes, analytes, and microbesMethods

Targeted Oncology Microarray Analysis

Institute for Genomic Medicine (IGM) Clinical Laboratory Nationwide Children's Hospital
United States
77
  • D Deletion/duplication analysis

Wilms tumor susceptibility-5, 601583, Autosomal dominant, Somatic mutation; WT5 (Nephroblastoma) (POU6F2 gene) (Sequence Analysis-All Coding Exons) (Postnatal)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • C Sequence analysis of the entire coding region

Wilms Tumor Panel

PreventionGenetics, part of Exact Sciences
United States
4828
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Wilms tumor: Full gene sequencing panel

CEN4GEN Institute for Genomics and Molecular Diagnostics
Canada
46
  • C Sequence analysis of the entire coding region

POU6F2 Single Gene

Fulgent Genetics
United States
11
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Results: 1 to 5 of 5

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.